Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission

Cited by (547)

Items 301–400 of 547

1. Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor Ameliorate Metabolic Disorder and Obesity Induced Cardiomyocyte Injury and Mitochondrial Remodeling
   Shih‐Jie Jhuo, Yi‐Hsiung Lin, I-Hsin Liu, Tsung‐Hsien Lin, Bin‐Nan Wu, Kun‐Tai Lee, Wen‐Ter Lai · 2023 · International Journal of Molecular Sciences
2. New Molecules in Type 2 Diabetes: Advancements, Challenges and Future Directions
   Kyriazoula Chatzianagnostou, Melania Gaggini, Adrian Florentin Suman, Ludovica Simonini, Cristina Vassalle · 2024 · International Journal of Molecular Sciences
3. SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art
   David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera Martínez, David Corredor-Rengifo, Jorge E. Rico-Fontalvo, Juan Esteban Gómez‐Mesa, John Jairo Duque Ossman, Alín Abreu-Lomba · 2024 · American Journal of Cardiovascular Drugs
4. Suppression of Tafazzin promotes thyroid cancer apoptosis via activating the JNK signaling pathway and enhancing INF2‐mediated mitochondrial fission
   Xiaobin Li, Mengwei Wu, Dawei An, Hongwei Yuan, Zengze Li, Yimin Song, Ziwen Liu · 2019 · Journal of Cellular Physiology
5. Cardiovascular and Renal Outcomes with Canagliflozin According to Baseline Diuretic Use: A Post Hoc Analysis from the CANVAS Program
   Jie Yu, Clare Gabrielle Arnott, Brendon Lange Neuen, H. J. Lambers Heersprink, Kenneth W. Mahaffey, Christopher Paul Cannon, Sadiya S. Khan, Abigail S. Baldridge, Sanjiv Jayendra Shah, Yuli Huang et al. · 2021 · ESC Heart Failure
6. Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial α1AMPK
   Marine Angé, Julien De Poortere, Audrey Ginion, Sylvain Battault, Mélanie Dechamps, Giulio G. Muccioli, Martin Roumain, Johann Morelle, Sébastien Druart, Thomas Mathivet et al. · 2021 · Scientific Reports
7. [Retracted] Protective Effect of Nicorandil on Cardiac Microvascular Injury: Role of Mitochondrial Integrity
   Xiaosi Jiang, Dan Wu, Zichao Jiang, Weiwei Ling, Geng Qian · 2021 · Oxidative Medicine and Cellular Longevity · Retracted
8. Ghrelin inhibits myocardial pyroptosis in diabetic cardiomyopathy by regulating ERS and NLRP3 inflammasome crosstalk through the PI3K/AKT pathway
   Fan Wang, Jingzhi Wang, Xinfang Liang, Zixuan Wu, Jiaxin Xue, Lingyu Yin, Lai Wei, Xiaohui Zhang · 2023 · Journal of drug targeting
9. RETRACTED ARTICLE: Sirtuin 3 inhibition induces mitochondrial stress in tongue cancer by targeting mitochondrial fission and the JNK-Fis1 biological axis
   Jichi Zhou, Menghan Shi, Man Li, Long Cheng, Jinsuo Yang, Xin Huang · 2019 · Cell Stress and Chaperones · Retracted
10. Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic Rats
    Qiuyue Lv, Liang Le, Jiamei Xiang, Baoping Jiang, Sibao Chen, Peigen Xiao · 2020 · Frontiers in Endocrinology
11. Structural Analysis of Mitochondrial Dynamics—From Cardiomyocytes to Osteoblasts: A Critical Review
    Daniel H. Mendelsohn, Katja Schnabel, Andreas Mamilos, Samuel Tobias Sossalla, Steffen Pabel, Georg Daniel Duerr, Karsten Keller, Volker H. Schmitt, Friedrich Barsch, Nike Walter et al. · 2022 · International Journal of Molecular Sciences
12. Capillaries as a Therapeutic Target for Heart Failure
    Yohko Yoshida, Ippei Shimizu, Tohru Minamino · 2022 · Journal of Atherosclerosis and Thrombosis
13. Sodium–Glucose Cotransporter 2 Inhibitors to Decrease the Uric Acid Concentration—A Novel Mechanism of Action
    Anna Kochanowska, Przemysław Rusztyn, Karolina Szczerkowska, Stanisław Surma, Aleksandra Gąsecka, Milosz Jaroslaw Jaguszewski, Łukasz Szarpak, Krzysztof Jerzy Filipiak · 2023 · Journal of Cardiovascular Development and Disease
14. The SGLT2 inhibitor empagliflozin inhibits skeletal muscle fibrosis in naturally aging male mice through the AMPKα/MMP9/TGF-β1/Smad pathway
    Qixuan Huang, Jie Chen, Siqi Liao, Jiangchuan Long, Ronghua Fang, Yusen He, Pei‐Yun Chen, Dongfang Liu · 2024 · Biogerontology
15. Melatonin attenuates renal fibrosis in diabetic mice by activating the AMPK/PGC1α signaling pathway and rescuing mitochondrial function
    Jian Li, Nan Li, Shuangtong Yan, Yanhui Lu, Xinyu Miao, Zhaoyan Gu, Yinghong Shao · 2018 · Molecular Medicine Reports
16. The YAP/SERCA2a signaling pathway protects cardiomyocytes against reperfusion-induced apoptosis
    Jiankai Zhong, Haichun Ouyang, Sulin Zheng, Zhongzhou Guo, Yuying Chen, Yuan‐Lin Zhong, Wenhao Zhong, Liuer Zuo, Jianhua Lu · 2020 · Aging
17. Zishen Huoxue decoction (ZSHX) alleviates ischemic myocardial injury (MI) via Sirt5-β-tubulin mediated synergistic mechanism of “mitophagy-unfolded protein response” and mitophagy
    Xing Chang, Siyuan Zhou, Yu Huang, Jinfeng Liu, Yanli Wang, Xuanke Guan, Qiaomin Wu, Zhiming Liu, Ruxiu Liu · 2025 · Chinese Journal of Natural Medicines
18. The role of AMPK signaling pathway in the pathogenesis of type 2 diabetes mellitus with its complications and related metabolic disorders
    Kibur Hunie Tesfa, Chernet Desalegn Gebeyehu, Asrat Tadele Ewunetie, Endalkachew Gugsa, Amare Nigatu Zewdie, Gashaw Dessie, Hiwot Tezera Endale · 2025 · Metabolism Open
19. RETRACTED ARTICLE: IL-2 augments the sorafenib-induced apoptosis in liver cancer by promoting mitochondrial fission and activating the JNK/TAZ pathway
    Xiaoyan Ding, Wei Sun, Jinglong Chen · 2018 · Cancer Cell International · Retracted
20. Liraglutide protects renal mesangial cells against hyperglycemia‑mediated mitochondrial apoptosis by activating the ERK‑Yap signaling pathway and upregulating Sirt3 expression
    Jian Li, Nan Li, Shuangtong Yan, Yanhui Lu, Xinyu Miao, Zhaoyan Gu, Yinghong Shao · 2019 · Molecular Medicine Reports · Retracted
21. AMPK/Drp1 pathway mediates Streptococcus uberis-Induced mitochondrial dysfunction
    Yuanyuan Zhou, Ming Li, Zhenglei Wang, Xinguang Lin, Yuanyuan Xu, Shiyuan Feng, Jinfeng Miao · 2022 · International Immunopharmacology
22. Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice
    Zichen Gui, Jiawen Wang, Yue Zhang, Bin-bin Wan, Zhiqiang Ke, Zhanhong Ren, Xiaosong Yang, Min Lei, Xiying Guo, Xiufen Liu et al. · 2023 · BioFactors
23. Effects of dapagliflozin monotherapy and combined aerobic exercise on skeletal muscle mitochondrial quality control and insulin resistance in type 2 diabetes mellitus rats
    Liangzhi Zhang, Hengjun Lin, Xudong Yang, Jipeng Shi, Xiusheng Sheng, Lifeng Wang, Ting Li, Helong Quan, Xia Zhai, Wei Li · 2023 · Biomedicine & Pharmacotherapy
24. Overexpression of Mst1 reduces gastric cancer cell viability by repressing the AMPK-Sirt3 pathway and activating mitochondrial fission
    Shi-Wei Yao, Wei Yan · 2018 · OncoTargets and Therapy · Retracted
25. Protective role of remogliflozin against experimental liver fibrosis by activating AMPK/SIRT1/Nrf2 and suppressing NF-κB pathways
    Naif Alsuhaymi, Mahdi H. Alsugoor, Aya A. Shokry, Hany M. Fayed, Bassim M. S. A. Mohamed, Sherif Mahmoud Afifi, Tuba Esatbeyoglu, Reda M. S. Korany, Marawan A. Elbaset · 2025 · Frontiers in Pharmacology
26. Effects of SGLT2 inhibitors on ion channels in heart failure: focus on the endothelium
    Mengnan Wang, Benedikt Preckel, Coert Jozef Zuurbier, Nina Claudia Weber · 2025 · Basic Research in Cardiology
27. RETRACTED ARTICLE: TAZ inhibition promotes IL-2-induced apoptosis of hepatocellular carcinoma cells by activating the JNK/F-actin/mitochondrial fission pathway
    Kaihua Ji, Kaili Lin, Yan Wang, Liqing Du, Chang Xu, Ningning He, Jinhan Wang, Liu Yang, Qiang Liu · 2018 · Cancer Cell International · Retracted
28. RETRACTED ARTICLE: Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathway
    Weilong Yao, Shengtao Zhu, Peng Li, Shutian Zhang · 2019 · Cancer Cell International · Retracted
29. Mitofusin-2 regulates inflammation-mediated mouse neuroblastoma N2a cells dysfunction and endoplasmic reticulum stress via the Yap-Hippo pathway
    Shu Hou, Lili Wang, Guoping Zhang · 2019 · The Journal of Physiological Sciences
30. Cardiomyocyte OTUD1 drives diabetic cardiomyopathy via directly deubiquitinating AMPKα2 and inducing mitochondrial dysfunction
    Xue Han, Ruyi Zheng, Jiajia Zhang, Yanan Liu, Ze Li, Guoxuan Liu, Jianing Zheng, Weiqi Li, Zi-Jun Liang, Mengyang Wang et al. · 2025 · Nature Communications
31. Sirt1 inhibits HG-induced endothelial injury: Role of Mff-based mitochondrial fission and F‑actin homeostasis-mediated cellular migration
    Ruijie Qin, Lina Zhang, Dong Lin, Fei Xiao, Lixin Guo · 2019 · International Journal of Molecular Medicine · Retracted
32. The Role of Mitochondrial Dynamin in Stroke
    Chenchen Li, Chunli Chen, Haiyun Qin, Chuncao Ao, Jinlun Chen, Jieqiong Tan, Liuwang Zeng · 2022 · Oxidative Medicine and Cellular Longevity
33. RETRACTED: Cytokine augments the sorafenib-induced apoptosis in Huh7 liver cancer cellby inducing mitochondrial fragmentation and activating MAPK-JNKsignalling pathway
    Lijuan Zhang, Shuping Li, Rong Wang, Changyuan Chen, Wen Ma, Hongyi Cai · 2018 · Biomedicine & Pharmacotherapy · Retracted
34. Nrf2 Alleviates Colistin-Induced Nephrotoxicity by Suppressing Ferroptosis via GPX4-Mediated Lipid Peroxidation and Mitochondrial Protection
    Zhisheng Hu, Weihua Hao, Wenqing Dai, Xin Gao, Na Cui, Min-Ge Wang, Liang‐Xing Fang, Jian Ge Sun, Hongyan Zhang, Xiao‐Ping Liao · 2025 · Journal of Agricultural and Food Chemistry
35. Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic Rats: A stereological and biochemical study
    Mina Kiani, Malek Soleimani Mehranjani, Seyed Mohammad Ali Shariatzadeh · 2024 · Biochemical Pharmacology
36. mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes
    Dario E. Troise, Silvia Mercuri, Barbara Infante, Vincenzo Losappio, Luciana Antonia Cirolla, Giuseppe Stefano Netti, Elena Ranieri, Giovanni Stallone · 2024 · International Journal of Molecular Sciences
37. Protein posttranslational modifications in metabolic diseases: basic concepts and targeted therapies
    Yunuo Yang, Jiaxuan Wu, Wenjun Zhou, Guang Ji, Yanqi Dang · 2024 · MedComm
38. Cardiorenal Syndrome in Heart Failure with Preserved Ejection Fraction: Insights into Pathophysiology and Recent Advances
    Harshwardhan Vinod Khandait, Sohail Singh Sodhi, Ninad Khandekar, Venugopal Brijmohan Bhattad · 2025 · Cardiorenal Medicine
39. Cellular and Molecular Pathways in Diabetes-Associated Heart Failure: Emerging Mechanistic Insights and Therapeutic Opportunities
    Nikolaos Ktenopoulos, Lilian Anagnostopoulou, Anastasiοs Apostolos, Panagιotis Iliakis, Paschalis Karakasis, Nikias Milaras, Panagiotis Theofilis, Christos Fragoulis, Maria Drakopoulou, Andreas G. Synetos et al. · 2025 · Current Issues in Molecular Biology
40. The naringin/carboxymethyl chitosan/sodium hyaluronate/silk fibroin scaffold facilitates the healing of diabetic wounds by restoring the ROS-related dysfunction of vascularization and macrophage polarization
    Hao Yang, Hailin Xu, Dongming Lv, Shuting Li, Yanchao Rong, Zhiyong Wang, Peng Wang, Xiaoling Cao, Xiaohui Li, Zhongye Xu et al. · 2024 · International Journal of Biological Macromolecules
41. Empagliflozin Ameliorates the Impaired Osteogenic Differentiation Ability of Adipose-Derived Stem Cells in Diabetic Osteoporosis by Activating Autophagy
    Shuanglin Yang, Ya‐Tin Lin, Yuping Xie, Ting Fu, Tianli Wu, Xiaorong Lan, Fangzhi Lou, Jingang Xiao · 2024 · Stem Cells
42. RETRACTED: Overexpression of macrophage stimulating 1 enhances the anti-tumor effects of IL-24 in esophageal cancer via inhibiting ERK-Mfn2 signaling-dependent mitophagy
    Jianpeng Zhang, Lin Sun, Weiqiang Li, Yanyu Wang, Xinzhen Li, Yang Liu · 2019 · Biomedicine & Pharmacotherapy · Retracted
43. Diabetes, Heart Failure and Beyond: Elucidating the Cardioprotective Mechanisms of Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors
    Utkarsh Ojha, Lenisse M. Reyes, Florence Eyenga, Diane Oumbe, Justyna Watkowska, Henock Saint-Jacques · 2021 · American Journal of Cardiovascular Drugs
44. ADENOSINE MONOPHOSPHATE–ACTIVATED PROTEIN KINASE PHOSPHORYLATION MEDIATED BY SIRTUIN 5 ALLEVIATES SEPTIC ACUTE KIDNEY INJURY
    Tingjie Wang, Bo Lin, Weihuang Qiu, Binmei Yu, Jiaxin Li, Sheng An, Lijun Weng, Yuying Li, Menglu Shi, Zhongqing Chen et al. · 2022 · Shock
45. Stress hyperglycemia ratio linked to worse prognosis in Cardiac Intensive Care Unit patients: A retrospective observational study
    Qianqian Zhang, Huaqiang Xiang, Qianqian Xu, Zesong Hu, Yangjing Xue, Jie Wang, Kangting Ji · 2024 · Diabetes Research and Clinical Practice
46. ROCK1 inhibition improves wound healing in diabetes via RIPK4/AMPK pathway
    Tianru Huyan, Lu Fan, Zhong-yuan Zheng, Jing-hui Zhao, Zhen-ru Han, Wu Pin, Qun Ma, Ya‐Qin Du, Yun-di Shi, Chunyan Gu et al. · 2024 · Acta Pharmacologica Sinica
47. Cardiovascular toxicity in antitumor therapy: biological and therapeutic insights
    Xuwen Lin, Xidong Ma, Sheng Zhao, Jie Yao, Leng Han, Ying Jing, Xinying Xue · 2024 · Trends in cancer
48. Growth differentiation factor 11 mitigates cardiac radiotoxicity via activating AMPKα
    Xia Li, Dong Ding, Wei Chen, Yu Liu, Haisong Pan, Jun X. Hu · 2021 · Free Radical Research
49. Biphasic effect of sulforaphane on angiogenesis in hypoxia via modulation of both Nrf2 and mitochondrial dynamics
    Yaqian Wang, Fangfang Chen, Yuan Zhang, Xiangyu Zheng, Shiyan Liu, Meijuan Tang, Ziling Wang, Pan Wang, Yongping Bao, Dan Li · 2022 · Food & Function
50. Clinical pharmacology of SGLT-2 inhibitors in heart failure
    Maria Velliou, Effie Polyzogopoulou, Ioannis Ventoulis, John Parissis · 2023 · Expert Review of Clinical Pharmacology
51. Heart failure with preserved ejection fraction and obesity: emerging metabolic therapeutic strategies
    Wenwen Zheng, Qianxian Qi, Jie Li, Chao‐Jie He, Hongyan Fan · 2025 · Diabetology & Metabolic Syndrome
52. SGLT2 inhibitors: further evidence for heart failure with preserved ejection fraction as a metabolic disease?
    Justin B. Echouffo-Tcheugui, Sabra C. Lewsey, Robert G. Weiss · 2021 · Journal of Clinical Investigation
53. Redox-driven cardioprotective effects of sodium-glucose co-transporter-2 inhibitors: comparative review
    Julia Hoehlschen, Dominik Hofreither, Tamara Tomin, Ruth Birner‐Gruenberger · 2023 · Cardiovascular Diabetology
54. Drp1-dependent mitochondrial fragmentation mediates photoreceptor abnormalities in type 1 diabetic retina
    Shuyu Tang, Mengling Huang, Ruixuan Wang, Ming Li, Ning Dong, Ronghan Wu, Zai‐Long Chi, Ling Gao · 2024 · Experimental Eye Research
55. RETRACTED ARTICLE: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathways
    Jun Wan, Jie Cui, Lei Wang, Kunpeng Wu, Xiaoping Hong, Yulin Zou, Shuang Zhao, Ke Hong · 2018 · Cancer Cell International · Retracted
56. RETRACTED: Yap-Hippo promotes A549 lung cancer cell death via modulating MIEF1-related mitochondrial stress and activating JNK pathway
    Jiayu Zhou, Shizhen Zhang, Zhijun Li, Zhoumiao Chen, Yong Xu, Weiwen Ye, Zhengfu He · 2019 · Biomedicine & Pharmacotherapy · Retracted
57. Empagliflozin suppresses urinary mitochondrial DNA copy numbers and interleukin-1β in type 2 diabetes patients
    Haekyung Lee, Hyoungnae Kim, Jin Seok Jeon, Hyunjin Noh, Rojin Park, Dong Won Byun, Hye Jeong Kim, Kyoil Suh, Hyeong Kyu Park, Soon Hyo Kwon · 2022 · Scientific Reports
58. Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications
    Moein Ebrahimi, Hamid Ahmadieh, Mozhgan Rezaei Kanavi, Sare Safi, Saeed Alipour-Parsa, Soroor Advani, Christine M. Sorenson, Nader Sheibani · 2025 · Frontiers in Medicine
59. Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus—Part 1
    Srikanth Yandrapalli, George P. Jolly, Adam M. Horblitt, Gayatri Pemmasani, Abdallah Sanaani, Wilbert S. Aronow, William H. Frishman · 2020 · Cardiology in Review
60. SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules
    Yajiao Wang, Xinxin Mao, Shuqing Shi, Xia Xu, Jiayu Lv, Bingxuan Zhang, Huaqin Wu, Qingqiao Song · 2023 · Frontiers in Nephrology
61. Pharmacological Progress of Mitophagy Regulation
    Sheikh Arslan Sehgal, Hao Wu, Muhammad Sajid, Summar Sohail, Muhammad Ahsan, Gulnaz Parveen, Mehreen Riaz, Muhammad Saleem Khan, Muhammad Nasir Iqbal, Abbeha Malik · 2023 · Current Neuropharmacology
62. Central administration of AICAR attenuates hypertension via AMPK/Nrf2 pathway in the hypothalamic paraventricular nucleus of hypertensive rats
    Liyan Fu, Yu Yang, Hua Tian, Xiu-Yue Jia, Kai‐Li Liu, Hong‐Li Gao, Ying Li, Jie Qi, Xiao-Jing Yu, Yu-Ming Kang · 2024 · European Journal of Pharmacology
63. Dapagliflozin Reduces Urinary Kidney Injury Biomarkers in Chronic Kidney Disease Irrespective of Albuminuria Level
    J.-H. Cho, Seung Whan Doo, Nayoung Song, M. Lee, Haekyung Lee, Hyongnae Kim, Jin Seok Jeon, Hyunjin Noh, Soon Hyo Kwon · 2024 · Clinical Pharmacology & Therapeutics
64. Canagliflozin reverses doxorubicin-induced cardiotoxicity via restoration of autophagic homeostasis
    Jianping Luo, Mingyuan He, Changzhu Liang, Xiaoxia Huang, Yingqi Zhu, Donghong Hu, Junyu Yan, Mingjue Li, Hairuo Lin, Wangjun Liao et al. · 2024 · Toxicology and Applied Pharmacology
65. Empagliflozin and memantine combination ameliorates cognitive impairment in scopolamine + heavy metal mixture-induced Alzheimer’s disease in rats: role of AMPK/mTOR, BDNF, BACE-1, neuroinflammation, and oxidative stress
    Ebtsam S Abdel-Lah, Hoda S. Sherkawy, Wafaa H. Mohamed, Mariam A. Fawy, Asmaa A. Hasan, Asmaa A. Muhammed, Amira F. Taha, Abeer A. Tony, Nashwa Hamad, Marwa G. Gamea · 2025 · Inflammopharmacology
66. RETRACTED: Empagliflozin and neohesperidin mitigate methotrexate hepatotoxicity via Nrf2/PPARγ/HO-1 signalling initiation and suppression of NF-κB/Keap1/ HSP70/caspase-3 axis in rats
    Adel T. Osman, Souty M.Z. Sharkawi, Mohamed I.A. Hassan, Amira M. Abo‐Youssef, Ramadan A.M. Hemeida · 2021 · Life Sciences · Retracted
67. Beta3‐Adrenergic Receptor Activation Alleviates Cardiac Dysfunction in Cardiac Hypertrophy by Regulating Oxidative Stress
    Mingming Zhang, Yuerong Xu, Jianghong Chen, Chaoshi Qin, Jing Liu, Dong Sheng Guo, Rui Wang, Jianqiang Hu, Qing Zou, Jingxiao Yang et al. · 2021 · Oxidative Medicine and Cellular Longevity · Retracted
68. The propofol-induced mitochondrial damage in fetal rat hippocampal neurons via the AMPK/P53 signaling pathway
    Fei Xiao, Yi Qin, Jing Chen, Chunlai Li, Yinying Qin, Wei Yi, Yubo Xie · 2022 · Annals of Translational Medicine
69. Circulating Angiokines Are Associated With Reverse Remodeling and Outcomes in Chronic Heart Failure
    Josephine Harrington, Andrew B. Nixon, Melissa A. Daubert, Eric S Yow, James L. Januzzi, Mona Fiuzat, David J. Whellan, Christopher M. O’Connor, Justin Adrian Ezekowitz, Ileana L. Piña et al. · 2023 · Journal of Cardiac Failure
70. Empagliflozin Protects against Haloperidol Experimentally-Induced Ovarian Toxicity
    Walaa Yehia Abdelzaher, Michel MDW DE WAARD, Alyaa Abdelfattah Abdelmonaem, Dalia Ali, Nashwa Fathy Gamal El‐Tahawy, Rehab Ahmed Rifaai, Hatem A. Mohamed, Kareem Shaheen, Mohamed Ahmed Zeen El-Din, Nermeen N. Welson et al. · 2023 · Pharmaceuticals
71. The Effect of SGLT2 Inhibition on Brain-related Phenotypes and Aging: A Drug Target Mendelian Randomization Study
    Zhihe Chen, Xueyan Wu, Qianqian Yang, Huiling Zhao, Hui Ying, Haoyu Liu, Chaoyue Wang, Ruizhi Zheng, Hong Lin, Shuangyuan Wang et al. · 2024 · The Journal of Clinical Endocrinology & Metabolism
72. Aflatoxin B1 Promotes Pyroptosis in IPEC-J2 Cells by Disrupting Mitochondrial Dynamics through the AMPK/NLRP3 Pathway
    Jiayi Ding, Xinyi Cheng, Chun Zeng, Qintao Zhao, Chenghong Xing, Caiying Zhang, Huabin Cao, Xiaoquan Guo, Guoliang Hu, Yu Zhuang · 2024 · Journal of Agricultural and Food Chemistry
73. Empagliflozin Plays Vasoprotective Role in Spontaneously Hypertensive Rats via Activation of the SIRT1/AMPK Pathway
    Monika Kloza, Anna Krzyżewska, Hanna Kozłowska, Sandra Budziak, Marta Baranowska‐Kuczko · 2025 · Cells
74. Insulin resistance, Ca2+ signaling alterations and vascular dysfunction in prediabetes and metabolic syndrome
    Tatiana Romero‐García, José Gustavo Vázquez-Jiménez, Rommel Sánchez-Hernández, Jesús Alberto Olivares-Reyes, Angélica Rueda · 2025 · Frontiers in Physiology
75. The use of SGLT2 inhibitors in older people: What is important?
    Giuseppe Armentaro, Raffaele Maio, Leonardo Bencivenga, Chukwuma Okoye, Giandomenico Severini, Velia Cassano, Valeria Zanobbi, Valentino Condoleo, Giuseppe Bellelli, Giuseppe Rengo et al. · 2025 · Aging Clinical and Experimental Research
76. Paradigm shift in heart failure treatment: are cardiologists ready to use gliflozins?
    Michele Correale, Renata Petroni, Stefano Coiro, Elena‐Laura Antohi, Francesco Monitillo, Marta Leone, Marco Triggiani, Shiro Ishihara, Hans‐Dirk Düngen, Chaudhry M. S. Sarwar et al. · 2021 · Heart Failure Reviews
77. LXR activation ameliorates high glucose stress-induced aberrant mitochondrial dynamics via downregulation of Calpain1 expression in H9c2 cardiomyoblasts
    Jiejin Lin, Fengdan Wang, Ge Jiang, Tiantian Zhang, Junfeng Zhang, Qing He, Yuqi Fan · 2022 · Biochemical and Biophysical Research Communications
78. Distinctive effects of SGLT2 inhibitors on angiogenesis in zebrafish embryos
    Roope J. Huttunen, Annele Sainio, Anja Hjelt, Anna-Mari Haapanen-Saaristo, Jorma A. Määttä, Petri Rummukainen, Ilkka Paatero, Hannu Järveläinen · 2022 · Biomedicine & Pharmacotherapy
79. Association of circulating MtDNA with CVD in hemodialysis patients and in vitro effect of exogenous MtDNA on cardiac microvascular inflammation
    Zhen Fan, Ya Feng, Li Zang, Yi Guo, Xiao-yi Zhong · 2023 · BMC Cardiovascular Disorders
80. Empagliflozin reduces endoplasmic reticulum stress associated TXNIP/NLRP3 activation in tunicamycin-stimulated aortic endothelial cells
    M. Campeau, R. Leask · 2023 · Naunyn-Schmiedeberg's Archives of Pharmacology
81. PTEN enhances nasal epithelial cell resistance to TNFα‑induced inflammatory injury by limiting mitophagy via repression of the TLR4‑JNK‑Bnip3 pathway
    Meng Li, Yang Xiang, Shouchuan Wang · 2018 · Molecular Medicine Reports
82. RETRACTED: DUSP1 alleviates cerebral ischaemia reperfusion injury via inactivating JNKMff pathways and repressing mitochondrial fission
    Peng Xu, Guofeng Zhang, Longgui Sha, Shuangxing Hou · 2018 · Life Sciences · Retracted
83. Protective Effect of Optic Atrophy 1 on Cardiomyocyte Oxidative Stress: Roles of Mitophagy, Mitochondrial Fission, and MAPK/ERK Signaling
    Yue Wang, Zhihua Han, Zuojun Xu, Junfeng Zhang · 2021 · Oxidative Medicine and Cellular Longevity
84. Cardiovascular Safety and Benefits of Noninsulin Antihyperglycemic Drugs for the Treatment of Type 2 Diabetes Mellitus: Part 2
    Srikanth Yandrapalli, Aaqib Habib Malik, Adam M. Horblitt, Gayatri Pemmasani, Wilbert S. Aronow, William H. Frishman · 2020 · Cardiology in Review
85. A simple but novel glycymicelle ophthalmic solution based on two approved drugs empagliflozin and glycyrrhizin: in vitro / in vivo experimental evaluation for the treatment of corneal alkali burns
    Zongjian Sun, Mingxin Zhang, Yanjun Wei, Mengshuang Li, Xianggen Wu, Meng Xin · 2023 · Biomaterials Science
86. Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism
    Chih‐Neng Hsu, Chin‐Feng Hsuan, Daniel Liao, Jack. Keng-Jui Chang, Allen Jiun-Wei Chang, Siow‐Wey Hee, Hsiao-Lin Lee, Sean I. F. Teng · 2023 · Life
87. Suramin protects hepatocytes from LPS-induced apoptosis by regulating mitochondrial stress and inactivating the JNK-Mst1 signaling pathway
    Aizhong Wang, Jiali Wang, Jun Wu, Xiaojun Deng, Yan Zou · 2019 · The Journal of Physiological Sciences
88. SGLT2 inhibitors: how do they affect the cardiac cells
    Betül Rabia Erdoğan, Ebru Arioglu‐Inan · 2024 · Molecular and Cellular Biochemistry
89. The interactive toxic effect of homocysteine and copper on cardiac microvascular endothelial cells during ischemia-reperfusion injury
    Xiaoming Liu, Haipeng Liu, Ning Wang, Songqing Lai, Chengpeng Qiu, Shansong Gao, Tianxiang Huang, Wan Zhang · 2025 · Chemico-Biological Interactions
90. Novel methotrexate long-acting system using ambroxol coating and hydroxypropyl methylcellulose encapsulation for preferential and enhanced lung cancer efficiency
    Samaa Abdullah, Najla Altwaijry, Meaad Alnakhli, Ghezlan ALenezi, Alaa A. Al-Masud, Hanan Ali Henidi, Yahya Fahad Jamous · 2025 · PLoS ONE
91. Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling
    Jingjing Zhang, Xue-Rui Ye, Xuesong Liu, Hao-Ling Zhang, Qian Qiao · 2025 · World Journal of Cardiology
92. Receptor-Interacting Protein Kinase 3 Suppresses Mitophagy Activation via the Yes-Associated Protein/Transcription Factor EB Pathways in Septic Cardiomyopathy
    Pingjun Zhu, Yangxiaocao Chen, Junyan Wang, Geng Lin, Runsheng Wang, Yifan Que, Jin Feng Zhou, Guogang Xu, Jiang Luo, Yingzhen Du · 2022 · Frontiers in Cardiovascular Medicine
93. Yes-associated protein reduces neuroinflammation through upregulation of Sirt3 and inhibition of JNK signaling pathway
    Yang Yang, Zhongying Gong, Zhiyun Wang · 2019 · Journal of Receptors and Signal Transduction
94. Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells
    Minwoo Song, Wenhao Cui, Chang-Gun Lee, Rihua Cui, Young Ho Son, Young Ha Kim, Yujin Kim, Hae Jin Kim, Sung‐E Choi, YUP Y. KANG et al. · 2023 · Frontiers in Pharmacology
95. Diabetes and Heart Failure: A Literature Review, Reflection and Outlook
    Xiya Li, Xiaoyang Zhou, Ling Gao · 2024 · Biomedicines
96. Ibrutinib Promotes Atrial Fibrillation by Disrupting A-Kinase Anchoring Protein 1-Mediated Mitochondrial Quality Surveillance in Cardiomyocytes
    Yukun Li, Xinmeng Liu, Rong Lin, Xiaodong Peng, Xuesi Wang, Fanchao Meng, Shuqi Jin, Wenhe Lv, Xiaoying Liu, Zhuohang Du et al. · 2024 · Research
97. Copper dyshomeostasis and its relationship to AMPK activation, mitochondrial dynamics, and biogenesis of mitochondria: A systematic review of in vivo studies
    Sarah Maria van Tol Amaral Guerra, Letícia Cordeiro Koppe de França, Katriane Neto da Silva, Fabielly Scolari Grotto, Viviane Glaser · 2024 · Journal of Trace Elements in Medicine and Biology
98. UCF101 Rescues against Diabetes-Evoked Cardiac Remodeling and Contractile Anomalies through AMP-Activated Protein Kinase-Mediated Induction of Mitophagy
    Zhiqiang Zhuang, Yuxi Zhu, Jun Tao, Yandong Liu, Jie Lin, Chunjie Yang, Chule Dong, Xing Qin, Qun Li, Russel Joseph Reiter et al. · 2024 · Pharmacology
99. Combined dapagliflozin and roxadustat effectively protected heart and kidney against cardiorenal syndrome-induced damage in rodent through activation of cell stress-Nfr2/ARE signalings and stabilizing HIF-1α
    Pei‐Hsun Sung, Ya Yue, Yi-Ling Chen, John Y. Chiang, Ben‐Chung Cheng, Chih‐Chao Yang, Han‐Tan Chai, Hon‐Kan Yip · 2024 · Biomedicine & Pharmacotherapy
100. Central SGLT2 mediate sympathoexcitation in hypertensive heart failure via attenuating subfornical organ endothelial cGAS ubiquitination to amplify neuroinflammation: Molecular mechanism behind sympatholytic effect of Empagliflozin
     Shutian Zhang, Yijun Huang, Chengzhi Han, Fanshun Wang, Maoxiang Chen, Shouguo Yang, Shouguo Yang, Chunsheng Wang · 2024 · International Immunopharmacology